Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health is a Finnish health technology company that aims to promote preventative health and help people stay healthy. Our blood analysis technology measures a large variety of biomarkers from a single blood sample and identifies personal risks for disease using unique health data assets. We provide people with comprehensive insights on health, help them make better decisions regarding their health and connect them with healthcare experts that offer preventative services for maintaining health. We strive to help millions of people prevent common lifestyle diseases in the future and, at the same time, to reduce the immense expenses of healthcare.
Contact us
ir@nightingalehealth.com
Share graph
Annual Report 2022–2023 has been published
Latest releases
Health check based on advanced blood analysis technology builds a better foundation for public health
Nightingale Health’s Board of Directors extended the subscription period of employee option rights
Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer
Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.
Nightingale Health’s technology used to analyze Uganda’s General Population Cohort (GPC)
Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc
Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc
Nightingale Health’s Half-year report: Healthcare implementations progressing in Finland and Singapore
Nightingale Health to publish half-year report for July – December 2023 on 7 March 2024
Subscribe to releases
Get the latest Nightingale Health releases delivered straight to your inbox.